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osting by EAbstract Several methods are available for detecting Helicobacter pylori infection: (1) invasive
methods based on gastric biopsies, (2) non invasive methods like Urea Breath Test (UBT), serology
and stool antigen tests. Importance of salivary PCR in detection ofH. pylori is still questionable. To
evaluate the role of salivary PCR technique in detecting H. pylori gastric affection in Egyptian
patients with dyspepsia and in differentiating between functional dyspepsia and acid-ulcer syn-
drome. This study included 60 patients with dyspepsia classiﬁed into three groups: (Group 1)
patients with gastric H. pylori and ulcers or erosions (n= 20), (Group 2) patients with gastric H.
pylori and no ulcers or erosions and had functional dyspepsia (n= 20), (Group 3) patients without
H. pylori and had functional dyspepsia (n= 20). All underwent upper gastrointestinal endoscopy
with biopsies, rapid urease test and salivary samples for H. pylori PCR. Signiﬁcant difference
between the three groups regarding salivary PCR values. No signiﬁcant difference between Group
1 and Group 2 but both had signiﬁcant difference with Group 3, signiﬁcant difference between
gastric H. pylori positive patients (n= 40) and negative ones (n= 20). Salivary PCR test had sen-
sitivity of 85%, speciﬁcity of 70% in diagnosing H. pylori. PCR value of 534000 Iu/ml had best sen-
sitivity (75%) and speciﬁcity (100%) for diagnosing H. pylori, highly signiﬁcant positive correlation26339843/226326590, mobile:
.
.com (W.A. Ibrahim).
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212 M.M. Sayed et al.between H. pylori gastric affection and salivary PCR values. No signiﬁcant difference between
patients with acid ulcer syndrome (n= 20) and those with functional dyspepsia (n= 40) as regard
salivary PCR mean values. Salivary PCR test showed sensitivity of 100%, speciﬁcity of 50% in dif-
ferentiating between patients with acid ulcer syndrome and those with functional dyspepsia. PCR
value of 440000 Iu/ml had best sensitivity (100%) and speciﬁcity (55%) in differentiating acid ulcer
syndrome from functional dyspepsia with non signiﬁcant. H. pylori salivary PCR may be of value in
diagnosing H. pylori gastric affection and is strongly correlated with it but it is of limited value in
differentiating between acid ulcer syndrome and functional dyspepsia.
 2011 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
It is estimated that 50% of the world’s population is infected by
Helicobacter pylori [1]. Around the world, the prevalence of H.
pylori infection ranges from 20% to over 90% in adult popula-
tions. Infection rates average at about 30% in Western popula-
tions while infection rates in Asian countries and in developing
countries are higher and range from 60% to 90% [2]. According
toMohammad et al. [3], the overall prevalence ofH. pylori infec-
tion was 72.38% among Egyptian school children.
H. pylori infection is associated with chronic gastritis, pep-
tic ulcers, atrophic gastritis, intestinal metaplasia, gastric ade-
nomas, gastric hyperplastic polyps, adenocarcinomas of the
distal part of the stomach, and lymphomas of mucosa-associ-
ated lymphoid tissue [4]. These diseases, in most instances, de-
velop many years after the host colonization [5]. The World
Health Organization has categorized H. pylori infection as a
deﬁnite human carcinogen class I since 1994 [6].
H. pylori infection can be diagnosed by invasive techniques
requiring endoscopy and biopsy (histological examination, cul-
ture, polymerase chain reaction) and by noninvasive tech-
niques (serology, urea breath test, detection of H. pylori
antigen in stool specimen) [7].
Human is the only known host of H. pylori. Its transmis-
sion route is not yet clearly understood. Epidemiological stud-
ies suggest person-to-person transmission, by either fecal–oral
or oral–oral routes, to be the major mechanism. In developing
countries, there is evidence for both food- and water-borne
transmission of H. pylori [8]. The human stomach is consid-
ered as the reservoir of this pathogen [9].
The ﬁrst documentation of the presence of H. pylori in the
oral cavity was reported in 1989, when the bacterium was
cultured from the dental plaque of one of 29 patients with
H. pylori associated gastric disease [10]. Since then, some re-
ports indicated that Helicobacter may be present in oral cavity
(particularly gingival pockets) which can serve as a reservoir
for bacteria and a source of gastric reinfection [11]. H. pylori
has also been detected by culture and PCR in both dental pla-
ques and saliva [12].
In 2006, ‘‘Rome III’’ classiﬁcation [13] functional dyspepsia
(FD) was included in the subcategory of functional gastrodu-
odenal disorders [14]. Of patients with functional dyspepsia,
30–60% carry H. pylori, but this prevalence is not much differ-
ent from that in the unaffected population [15]. Various studies
have focused on the effect of H. pylori eradication in patients
with both functional and uninvestigated dyspepsia. A meta-
analysis of 13 randomized studies of functional (non-ulcer)
dyspepsia showed that H. pylori eradication was associated
with an 8% relative risk reduction compared with placebo [16].2. Aim of the work
This study aimed to evaluate the role of salivary PCR technique
in detectingH. pylori gastric affection in Egyptian patients with
dyspepsia and in differentiating between functional dyspepsia
and acid-ulcer syndrome.
3. Patients and methods
In this study 60 dyspeptic patients (deﬁned symptomatically as
abdominal discomfort related to meal) attending the outpa-
tient clinics of Internal Medicine and Tropical Medicine
Departments, Ain Shams University Hospital were included
after approval of the ethical committee and the taking of their
informed consent.
All patients with hepatic, pulmonary, renal and cardiac
diseases or with contraindication to endoscopy were excluded
from the study. All studied patients did not receive non-steroi-
dal anti-inﬂammatory drugs (NSAIDs), proton pump inhibi-
tors (PPI) or antibiotics within the previous two months.
All studied patients were subjected to: History taking,
Complete clinical examination, Complete blood picture, Kid-
ney function tests (urea and creatinine), Liver function tests
(SGOT, SGPT, serum bilirubin, serum albumin, prothrombin
time). Upper GIT endoscopy by the same operator: to evaluate
for the presence of gastritis, erosions or ulcers. Four quadrant
biopsies were taken from antral mucosa within 5 cm of the
pyloric opening for detection of H. pylori infection using [(1)
rapid urease test (2) Histopathological examination] and Sali-
vary PCR for H. pylori DNA.
 Rapid urease test: One biopsy specimen was placed in urea
broth, incubated at 37 C, and examined after 4 hours and
after overnight incubation. Urease positive test changed the
color of the indicator from yellow to purple – pink [27].
 Histopathological examination: Biopsy taken from antral
mucosa was ﬁxed in 10% buffer formalin and was prepared
from parafﬁn block for modiﬁed Giemsa stain for detection
of H. pylori [27].
 Salivary PCR for H. pylori DNA examination: Saliva sam-
ples (2–3 ml) were collected in a sterile container prior to
endoscopy. DNA extraction was done with MagNA pure
compact Nucleic Acid Isolation Kit (Roche Diagnostics
Nederland BV) according to themanufacturer’s instructions.
Real-time PCR was performed with a Light Cycler (Roche,
Mannheim, Germany). for Real-Time PCR analysis, The
nucleic acid sequence for the oligonucleotide primer pairs
speciﬁc for two sequences ﬂanking an internal 294 bp frag-
ment of the ureaseCgene ofH. pylori, These oligonucleotides
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TTA GGG GTT T-30 and for the Reverse primer was 50
AAG CTT ACT TTC TAA CAC TAA CGC 30 both were
supplied by Tip Mol Biol, USA. Master mix was prepared
to reach a total volume of 20 ll: (5.0 ll 10X reaction buffer,
5.0 ll dNTPs 10 mM, primer set ﬁnal 100 nM each (forward
& reverse primers), 0.5 ll Prime Taq DNA polymerase
(DNA plasmid)(Quality, Genet Bio Roche diagnostic, with
Syber Green buffer, Korea), serial dilution of positive stan-
dard control 107–102 copies/ml for calibration curve, 5.0 ll
DNA, RNAse-free water). The thermal cycler was pro-
grammed in three steps: (Step l: 5 min at 94 C, Step 2: 30
sec. at 94 C, 30 sec. at 52C. 1 min at 72 C, thiswas repeated
for 35 cycles, Step 3: 5 min at 72 C) [28].
According to the results of upper GIT endoscopy, H. pylori
rapid urease and histopathology, selected patients were divided
into 3 groups. Group 1: Patients conﬁrmed to be gastric H. py-
lori positive and with ulcers or erosions (20 patients). Group 2:
Patients with functional dyspepsia (according to Rome III cri-
teria) conﬁrmed to be gastric H. pylori positive without ulcers
or erosions (20 patients). Group 3: Patients with functional
dyspepsia (according to Rome III criteria) proved to be gastric
H. pylori negative (20 patients).
3.1. Statistical analysis
Data were collected, revised, veriﬁed, and then edited and ana-
lyzed statistically using Statistical Package for Social Sciences
program (SPSS v16).The following tests were used in this
study: mean, standard deviation, T test for independent
samples, ANOVA test (analysis of variance), Post Hoc test,
Spearman coefﬁcient of rank correlation (rho), ROC curve
analysis. Signiﬁcance levels: P>0.05 insigniﬁcant, P<0.05 sig-
niﬁcant and P<0.001 highly signiﬁcant.
4. Results
This study included 32 males (53%) and 28 females (47%) pre-
sented with dyspepsia (deﬁned as abdominal discomfort re-
lated to meals) with their mean age of 35.63 ± 14.23 years.
Patients were divided into three groups:
Group 1: their mean age was 41.4 ± 15.1 years, (60%
males and 40% females).
Group 2: their mean age was 36.8 ± 16.7 years, (50%
males and 50% females).
Group 3: their mean age was 28.7 ± 7.34 years, (50%
males and 50% females).
 Salivary PCR test was positive in 20 /20 patients (100%)
of Group 1, 14/20 (70%) of Group 2 and 6/20 (30%) of
Group 3.Table 1 Comparison between the three groups as regard salivary P
Salivary PCR Group 1 (n= 20)
Mean 948300
SD ±388252.22
F 6.950
P 0.04 (S) On comparing the three groups as regard H. pylori sali-
vary PCR values Table 1, we found signiﬁcant difference
between the three groups (P= 0.04) with patients with
functional dyspepsia and gastric H. pylori (Group 2)
showed the highest values. Post hoc analysis revealed that
there was no signiﬁcant difference between Group 1 and
Group 2 (P= 0.3018) but there was signiﬁcant difference
between Group 1 and Group 3 (P= 0.0056) (Group 1
mean values were higher than Group 3) and highly
signiﬁcant difference between Group 2 and Group 3 (P
< 0.0001) (Group 2 mean values were higher than
Group 3).
 Comparison between gastric H. pylori positive patients
(n= 40) and gastric H. pylori negative patients (n= 20)
(regarding salivary PCR test):
1. There was signiﬁcant difference between both groups
(P= 0.0017) with gastricH. pylori positive patients hav-
ing higher salivary PCR mean value Table 2.
2. Among the 40 gastric H. pylori positive patients, 34
patients (85%) had positive salivary PCR. While among
the 20 gastric H. pylori negative ones, only 6 patients
(30%) showed positive salivary PCR. This gives the
PCR test sensitivity of 85%, speciﬁcity of 70%, positive
predictive value of 85% and negative predictive value of
70% in diagnosing H. pylori affection Table 3.
3. The ROC curve analysis showed that the best cutoff
value for diagnosing H. pylori positivity by salivary
PCR was 534000 Iu/ml with the best sensitivity (75%)
and speciﬁcity (100%) and highly signiﬁcant P-value
(P= 0.0001)
4. Spearman coefﬁcient of rank correlation showed highly
signiﬁcant positive correlation (rho = 0.649) between
H. pylori gastric affection and salivary PCR
(P= 0.0001).
 Comparison between patients with acid ulcer syndrome
(n= 20) and those with functional dyspepsia (n= 40):
1. There was no signiﬁcant difference between both groups
as regards salivary PCR mean values (P= 0.598)
(Table 2).
2. Salivary PCR test was positive in 20/20 patients (100%)
with acid ulcer syndrome and in 20/40 patients (50%)
with functional dyspepsia. This gives the test a sensitiv-
ity of 100%, speciﬁcity of 50%, positive predictive value
of 50% and negative predictive value of 100% in differ-
entiating between patients with acid ulcer syndrome and
those with functional dyspepsia (Table 3).
3. The ROC curve analysis showed that the best cutoff
value for differentiating acid ulcer syndrome from
functional dyspepsia by salivary PCR was 440000 Iu/
ml with the best sensitivity (100%) and speciﬁcity
(55%) but with non signiﬁcant P-value (P= 0.0508)
(Fig. 1).CR values.
Group 2 (n= 20) Group 3 (n= 20)
1378800 144500
±1220199 ±233760.20
Table 2 Comparison between gastric H. pylori positive and negative patients and comparison between patients with acid ulcer
syndrome and those with functional dyspepsia (regarding salivary PCR test).
Salivary
PCR
Gastric H. pylori positive
(n= 40)
Gastric H. pylori negative
(n= 20)
Acid ulcer syndrome
(n= 20)
Functional dyspepsia
(n= 40)
Mean 1163550 144500 948300 761650
SD ±908534.9384 ±233760.2048 ±388252.2233 ±1063985.7179
T-test 3.462 0.533
P 0.0017 (S) 0.5980 (NS)
Table 3 Salivary PCR test in diagnosing H. pylori affection and in differentiating between acid ulcer syndrome and functional
dyspepsia.
Parameter Gastric H. pylori
positive (n= 40)
Gastric H. pylori
negative (n= 20)
Acid ulcer syndrome
(n= 20)
Functional dyspepsia
(n= 40)
Salivary PCR
positive
34 6 20 20
Salivary PCR
negative
6 14 0 20
Sensitivity = 85%, speciﬁcity = 70%, positive predictive value = 85%
negative predictive value = 70%
Sensitivity = 100% speciﬁcity = 50% positive predictive
value = 50% negative predictive value = 100%
Concentration Iu / ml
0 20 40 60 80 100
100
80
60
40
20
0
100-Specificity
Se
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Figure 1 Salivary PCR ROC curve for differentiating between
acid ulcer syndrome and functional dyspepsia patients.
214 M.M. Sayed et al.5. Discussion
Recent studies have demonstrated that H. pylori can be found
in the human oral cavity as it provides an excellent microaer-
ophilic environment, therefore, being a potential reservoir for
H. pylori. It is unclear whether the oral cavity is a permanent
or transient reservoir [12,17,18]. Souto and Colombo [19]
found that 20% and 33% of subjects had positive samples in
saliva and dental plaque, respectively.
One of the ﬁrst investigations of the inﬂuence of oral H. py-
lori on stomach infection was carried out by Miyabayashi et al.
[20]. Their study revealed that there is relationship betweengastritis induced by H. pylori infection and oral colonization
of the bacterium and that oral H. pylori is resistant to typical
triple anti-H. pylori therapy used to eradicate it from the stom-
ach. So, patients with oral H. pylori were at a signiﬁcantly
greater risk of gastric reinfection following successful therapy.
Both cultures and urease tests carried out on the oral cavity
samples revealed that the methodology used for the detection
of H. pylori is not sufﬁciently sensitive for the detection of
the microorganism in the oral cavity [22,23]. Successful ampli-
ﬁcation and speciﬁc detection of H. pylori DNA directly from
salivary samples in the majority of infected subjects indicates
that this approach is feasible and demonstrates that it has true
potential in aiding the diagnosis and management of patients
with active H. pylori infection [21]. But the results of salivary
PCR are still conﬂicting and differ among various studies.
Rasmussen et al. [24] studied 78 adults presenting with
recurrent abdominal pain. H. pylori infection was conﬁrmed
from gastric biopsies using PCR, Southern blotting, histology
and urease test and compared the results with salivary PCR
technique results. Of the 66 patients who were H. pylori posi-
tive in their gastric biopsies, salivary PCR was positive in
71.2%. Salivary PCR was positive in 50% of gastric H. pylori
negative patients. A statistically signiﬁcant correlation was
observed between the presence of H. pylori in the gastric biop-
sies and the oral cavity (P <0.0001).
Tiwari et al. [21] studied one hundred patients (80 symp-
tomatic with dyspepsia and 20 asymptomatic) who underwent
gastroscopy and were investigated for the presence of H. pylori
in saliva and stomach. Seventy two of the symptomatic group
and ten asymptomatic subjects were infected with H. pylori in
the stomach as determined by histology and direct PCR ampli-
ﬁcation of gastric biopsy DNA obtained from each subject. H.
pyloriDNA was identiﬁed in the saliva of seventy symptomatic
subjects and twelve asymptomatic control subjects.
In the study performed by Silva et al. [25], H. pylori was not
detected in saliva in any of the control group (individuals with
no gastric disease who were H. pylori positive). In the case
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positive) H. pylori DNA was detected in 16/30 (53.3%) saliva
samples.
In the current study, there was signiﬁcant difference
(P= 0.0017) between group of patients with gastric H. pylori
infection (n= 40) and those without (n= 20) as regard sali-
vary PCR values. Patients having gastric H. pylori infection
showed higher salivary PCR mean values (1163,550 vs.
144,500, respectively). Thirty four out of the forty gastric H.
pylori positive patients (85%) had positive salivary PCR. On
the other hand, 6 out of the 20 gastric H. pylori negative
patients (30%) were H. pylori positive by salivary PCR. Our
results showed lower detection rates than the results of Tiwari
et al. [21].On the contrary, this study results showed higher
detection rates than those reported by Silva et al. [25] and Ras-
mussen et al. [24]. This study is not in agreement with the study
of Kignel et al. [26] who found that of the 20 patients with H.
pylori detected by rapid urease in the stomach, the organism
was detected in none of the salivary samples by PCR (0%).
The discrepancies in the detection rates of H. pylori by
salivary PCR test that were found between the current study
and other studies may be attributed to factors affecting PCR
accuracy. These factors include the choice of primers and tar-
get DNA, specimen preparation, bacterial density, and techni-
cal issues regarding the PCR procedure [29]. Previous
investigators stated that because H. pylori in saliva generally
reﬂects the reﬂux of organisms from the stomach, their detec-
tion rates may vary. There is also the possibility of cross-reac-
tivity with spiral urease-containing organisms normally
present in the mouth, especially if primer pairs are not care-
fully selected [30].
Our results showed highly signiﬁcant positive correlation
between H. pylori gastric affection and salivary PCR values
(rho = 0.649, P= 0.0001). This is consistent with the results
of Rasmussen et al. [24]. On evaluating the role of salivary
PCR in H. pylori gastric detection, salivary PCR test had a
sensitivity of 85%, speciﬁcity of 70%, positive predictive value
of 85% and negative predictive value of 70% making this test
valuable in diagnosing H. pylori gastric affection. Using ROC
curve analysis, salivary PCR test showed best sensitivity (75%)
and speciﬁcity (100%) for diagnosing H. pylori gastric positiv-
ity at cutoff value of 534,000 Iu/ml with highly signiﬁcant
P-value (P= 0.0001).
PCR values were higher in patients with functional dyspep-
sia and gastric H. pylori (group2) followed by patients with ul-
cers or erosions and H. pylori (group 1) then patients with
functional dyspepsia who are gastric H. pylori negative (group
3). There was no signiﬁcant difference between Group 1 and
Group 2, but there was signiﬁcant difference between each
group and group 3.
On evaluating the role of salivary PCR test as a tool in dif-
ferentiating acid ulcer syndrome patients (n= 20) from func-
tional dyspepsia patients (n= 40), we found no signiﬁcant
difference between both groups as regard salivary PCR mean
values (P= 0.598) and salivary PCR test was not of value
making differentiation between both groups.
6. Conclusion
Helicobacter pylori salivary PCR may be of value in diagnos-
ing H. pylori gastric affection and is strongly correlated withit but it is of limited value in differentiating between acid ulcer
syndrome and functional dyspepsia.
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